US Patent Issued to Sichuan Gooddoctor Panxi Pharmaceutical on July 8 for "Polypeptide for repairing mucosal damage or skin wound and use thereof" (Chinese Inventor)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,651, issued on July 8, was assigned to Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd. (Xichang, China).

"Polypeptide for repairing mucosal damage or skin wound and use thereof" was invented by Funeng Geng (Xichang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a new polypeptide for repairing mucosal damage or a skin wound, and the use thereof. The polypeptide is not homologous with known polypeptides, can be stably present in vivo and in vitro, and has the effect of regulating stem cell proliferation and differentiation to repair mucosal damage or a skin wound. The present invention further relates to the use of the new polypept...